CNS Pharmaceuticals, Inc. (CNSP) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 4 Buy.
The consensus price target is $0.50, representing a downside of 81.1% from the current price $2.64.
Analysts estimate Earnings Per Share (EPS) of $-495.48 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-38.87 vs est $-495.48 (beat +92.2%). 2025: actual $-35.75 vs est $-27.43 (missed -30.3%). Analyst accuracy: 0%.
CNSP Stock — 12-Month Price Forecast
$0.50
▼ -81.06% Downside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for CNS Pharmaceuticals, Inc., the price target is $0.50.
The average price target represents a -81.06% change from the last price of $2.64.
CNSP Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to CNS Pharmaceuticals, Inc. in the past 3 months
EPS Estimates — CNSP
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$38.87
vs Est –$495.48
▲ 1,174.7% off
2025
Actual –$35.75
vs Est –$27.43
▼ 23.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — CNSP
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
